Checkmate Pharmaceuticals, Inc.
CMPIDelisted May 31, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001651431
Checkmate Pharmaceuticals, Inc. was delisted on May 31, 2022; its insiders filed their last Form 4 on May 31, 2022; 26 institutions reported holding it in 13F filings for Q1 2022, worth $54.8M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Checkmate Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 34 | 32 | −2 |
| Shares | 16.3M | 16.4M | +30.5K (+0.2%) |
| Value | $97.3M | $64.5M | −$32.8M (−33.7%) |
New holders (4)
Institutions that held Checkmate Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jacobs Levy Equity Management, Inc | 36,511 | $145.0K | 0.00% |
| State Street Corp | 11,087 | $44.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,426 | $6.00K | 0.00% |
| Hall Laurie J Trustee | 100,530 | $0 | 0.00% |
Sold out (6)
Institutions that held Checkmate Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Deutsche Bank AG | 134,760 | $803.0K |
| Millennium Management LLC | 40,422 | $241.0K |
| Alberta Investment Management Corp | 25,000 | $149.0K |
| Advisory Services Network, LLC | 7,800 | $46.0K |
| New York State Common Retirement Fund | 77 | $0 |
| Citigroup Inc | 1 | $0 |